If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,127.50    1.00 (0.09%)
Bid:
1,127.50
Ask:
1,128.50
Spread: 1.00 (0.089%)
Market Cap: £9.53b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

13 Aug 2025 17:08

RNS Number : 2390V
Smith & Nephew Plc
13 August 2025
 

SMITH & NEPHEW PLC

 

13 August 2025

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020

 

On 13 August 2025, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.

 

All figures in these columns are stated to 6 decimal places where applicable.

 

 

PARTIAL VESTING OF 2023 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:

 

The awards were granted under the Global Share Plan 2020 on 11 August 2023. One third of the award vests in equal tranches over the following three years. A number of shares were sold to cover taxation obligations arising on the vesting of the awards.

 

The following relates to individuals included in the below notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Partial vesting on 12 August 2025 of Conditional Share awards granted on 11 August 2023 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability

Date of Transaction

2025 - 08 - 12

Place of Transaction

London Stock Exchange (XLON)

 

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Rohit Kashyap

(President, Advanced Wound Management and Global

PDMR

13.571365

23,201 (of which 5,670 were sold and 17,531 were retained.)

N/A Single Transaction

 

 

 

Helen Barraclough

Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFIRTEIVLIE
Date   Source Headline
31st Oct 20184:00 pmRNSDirector/PDMR Shareholding
18th Oct 20183:54 pmRNSDividend Declaration
17th Oct 20187:00 amRNSNotice of Results
5th Oct 20184:36 pmRNSDirector/PDMR Shareholding
1st Oct 20181:29 pmRNSTotal Voting Rights
1st Oct 20187:00 amRNSNotice of Results
19th Sep 20188:48 amRNSDirector/PDMR Shareholding
3rd Sep 20181:23 pmRNSTotal Voting Rights
23rd Aug 20184:42 pmRNSDirector/PDMR Shareholding
16th Aug 20182:03 pmRNSDirector/PDMR Shareholding
16th Aug 20182:01 pmRNSDirector/PDMR Shareholding
9th Aug 201811:31 amRNSAdditional Listing
2nd Aug 20183:25 pmRNSTransaction in Own Shares
2nd Aug 20189:42 amRNSDirector/PDMR Shareholding
1st Aug 20183:07 pmRNSTransaction in Own Shares
1st Aug 201812:30 pmRNSBlock listing Interim Review
1st Aug 201811:47 amRNSTotal Voting Rights
31st Jul 20185:33 pmRNSTransaction in Own Shares
30th Jul 20189:16 amRNSTransaction in Own Shares
26th Jul 20187:00 amRNSHalf-year Report
11th Jul 20184:26 pmRNSDirector/PDMR Shareholding
4th Jul 20187:00 amRNSNotice of Results
2nd Jul 201812:24 pmRNSTotal Voting Rights
1st Jun 201812:24 pmRNSTotal Voting Rights
30th May 20182:26 pmRNSTransaction in Own Shares
23rd May 20185:47 pmRNSTransaction in Own Shares
22nd May 20185:38 pmRNSTransaction in Own Shares
18th May 20185:47 pmRNSTransaction in Own Shares
17th May 20185:58 pmRNSTransaction in Own Shares
16th May 20186:02 pmRNSTransaction in Own Shares
15th May 20183:01 pmRNSDirector/PDMR Shareholding
15th May 20189:39 amRNSTransaction in Own Shares
11th May 201810:06 amRNSDirector/PDMR Shareholding
10th May 20182:47 pmRNSDirector/PDMR Shareholding
10th May 20189:18 amRNSDirector/PDMR Shareholding
9th May 20185:25 pmRNSDirector/PDMR Shareholding
9th May 20181:50 pmRNSDirector/PDMR Shareholding
9th May 20188:09 amRNSDirector/PDMR Shareholding
8th May 201811:45 amRNSDirectorate Change
3rd May 20187:00 amRNSTrading Statement
1st May 201811:39 amRNSTotal Voting Rights
25th Apr 20188:47 amRNSDividend Declaration
18th Apr 20189:00 amRNSNotice of Results
18th Apr 20188:00 amRNSECC endorsed by Royal College of Surgeons
12th Apr 20184:12 pmRNSResult of AGM
9th Apr 20184:40 pmRNSDirector/PDMR Shareholding
4th Apr 20187:00 amRNSDirectorate Change
3rd Apr 20181:15 pmRNSTotal Voting Rights
12th Mar 201812:18 pmRNSDirector/PDMR Shareholding
8th Mar 20181:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.